Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilfried Roth

Showing results (151-160 of 196) with videos related to

Pageof 20
Sort By:
Journal of Endourology|July 9, 2015
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a StandardJan Philipp Radtke, Boris A Hadaschik, Maya B Wolf, et al.
The American Journal of Pathology|August 21, 2024
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate CancerMaximilian P Brandt, Olesya Vakhrusheva, Hubert Hackl, et al.
The Journal of Urology|August 1, 2014
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidanceJan P Radtke, Timur H Kuru, Silvan Boxler, et al.
Clinical Genitourinary Cancer|March 18, 2020
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell CarcinomaUlrich Sommer, Markus Eckstein, Johannes Ammann, et al.
European Urology Focus|November 28, 2018
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical ProstatectomyJoanne Nyarangi-Dix, Manuel Wiesenfarth, David Bonekamp, et al.
Oncotarget|July 25, 2016
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progressionJulia M A Pickl, Diana Tichy, Vladimir Y Kuryshev, et al.
Histopathology|September 16, 2020
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancerAurelia Noske, Johannes U Ammann, Daniel-Christoph Wagner, et al.
Nature Communications|April 30, 2020
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomasAswini Krishnan, Jean Berthelet, Emilie Renaud, et al.
Brain Pathology (Zurich, Switzerland)|March 29, 2007
Microsatellite instability in pediatric and adult high-grade gliomasAnika Eckert, Matthias Kloor, Antje Giersch, et al.
Cell Death & Disease|October 27, 2017
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenibCristina Quintavalle, Sravanth Kumar Hindupur, Luca Quagliata, et al.
Pageof 20

Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
Journal of Endourology|July 9, 2015
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a StandardJan Philipp Radtke, Boris A Hadaschik, Maya B Wolf, et al.
The American Journal of Pathology|August 21, 2024
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate CancerMaximilian P Brandt, Olesya Vakhrusheva, Hubert Hackl, et al.
The Journal of Urology|August 1, 2014
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidanceJan P Radtke, Timur H Kuru, Silvan Boxler, et al.
Clinical Genitourinary Cancer|March 18, 2020
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell CarcinomaUlrich Sommer, Markus Eckstein, Johannes Ammann, et al.
European Urology Focus|November 28, 2018
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical ProstatectomyJoanne Nyarangi-Dix, Manuel Wiesenfarth, David Bonekamp, et al.
Oncotarget|July 25, 2016
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progressionJulia M A Pickl, Diana Tichy, Vladimir Y Kuryshev, et al.
Histopathology|September 16, 2020
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancerAurelia Noske, Johannes U Ammann, Daniel-Christoph Wagner, et al.
Nature Communications|April 30, 2020
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomasAswini Krishnan, Jean Berthelet, Emilie Renaud, et al.
Brain Pathology (Zurich, Switzerland)|March 29, 2007
Microsatellite instability in pediatric and adult high-grade gliomasAnika Eckert, Matthias Kloor, Antje Giersch, et al.
Cell Death & Disease|October 27, 2017
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenibCristina Quintavalle, Sravanth Kumar Hindupur, Luca Quagliata, et al.
Pageof 20